Bumetanide
Thông số
28395-03-1Số CAS
249-004-6Số EC
3-(butylamino)-4-phenoxy-5-sulfamoylbenzoic acidTên IUPAC
C17H20N2O5SCông thức hóa học
364.4 g/molKhối lượng phân tử
bumetanide; 28395-03-1; 3-(Butylamino)-4-phenoxy-5-sulfamoylbenzoic acid; Bumex; Burinex; Bumetanida; Ro 10-6338; Bumetanidum; Lixil; 3-(Aminosulfonyl)-5-(butylamino)-4-phenoxybenzoic acid; PF 1593; Benzoic acid, 3-(aminosulfonyl)-5-(butylamino)-4-phenoxy-; PF-1593; DTXSID5022699; PF1593; Ro-10-6338; 0Y2S3XUQ5H; CHEBI:3213; Bumethanide; 3-butylamino-4-phenoxy-5-sulfamoylbenzoic acid; BENZOIC ACID, 3-(BUTYLAMINO)-4-PHENOXY-5-SULFAMOYL-; 3-butylamino-4-phenoxy-5-sulfamoyl-benzoic acid; 3-butylamino-4-(phenoxy)-5-sulfamoylbenzoic acid; Ro-106338; RO10-6338; DTXCID702699; S95008.; S-95008.; Betinex; RefChem:57582; C03CA02; 249-004-6; Fordiuran; Lunetoron; Fontego; Segurex; Bufenox; Bumetanidum [INN-Latin]; Bumetanida [INN-Spanish]; C17H20N2O5S; MFCD00078949; MLS000028457; Aquazone; Butinat; Cambiex; Diurama; Yurinex; Burine; Lixil-Leo; 3-(butylamino)-4-phenoxy-5-sulfamoyl-benzoic acid; NCGC00015149-02; SMR000058418; CAS-28395-03-1; Ro 10-6338;PF 1593; Bumex (TN); SR-01000003062; EINECS 249-004-6; UNII-0Y2S3XUQ5H; BRN 2185351; Bumetanide?; Bumetanide CRS; Bumetanide in bulk; 82U; Bumetanide; 3-(Butylamino)-4-phenoxy-5-sulfamoylbenzoic acid; Benzoic acid, 3-(aminosulfonyl)-5-(butylamino)-4-phenoxy-; Benzoic acid, 3-(butylamino)-4-phenoxy-5-sulfamoyl- (8CI); 3-(Aminosulfonyl)-5-(butylamino)-4-phenoxybenzoic acid; 3-(Butylamino)-4-ph; Prestwick_679; ENBUMYST; Bumetanide [USAN:USP:INN:BAN:JAN]; Bumetanide (Standard); Spectrum_001317; Bumetanide, >=98%; BUMETANIDE [MI]; BUMETANIDE [INN]; BUMETANIDE [JAN]; Opera_ID_1734; Prestwick0_000276; Prestwick1_000276; Prestwick2_000276; Prestwick3_000276; Spectrum2_001050; Spectrum3_001481; Spectrum4_000030; Spectrum5_001212; BUMETANIDE [USAN]; Lopac-B-3023; BUMETANIDE [VANDF]; Epitope ID:613420; B 3023; BUMETANIDE [MART.]; cid_2471; BUMETANIDE [USP-RS]; BUMETANIDE [WHO-DD]; CHEMBL1072; Lopac0_000162; SCHEMBL27525; BSPBio_000152; BSPBio_001508; BSPBio_003061; KBioGR_000228; KBioGR_000439; KBioSS_000228; KBioSS_001797; MLS001148265; orb134445; DivK1c_000034; SPECTRUM1502004; SPBio_000980; SPBio_002371; BPBio1_000168; Bumetanide (JP18/USP/INN); GTPL4837; 3-(aminosulfonyl)-5-(butylamino)-4-phenoxy-benzoic acid; BUMETANIDE [EP IMPURITY]; BUMETANIDE [ORANGE BOOK]; SCHEMBL29388271; BDBM25903; HMS500B16; KBio1_000034; KBio2_000228; KBio2_001797; KBio2_002796; KBio2_004365; KBio2_005364; KBio2_006933; KBio3_000455; KBio3_000456; KBio3_002561; BUMETANIDE [EP MONOGRAPH]; NINDS_000034; 3-(aminosulfonyl)-5-(butylamino)-4-(phenyloxy)benzoic acid; Bio1_000421; Bio1_000910; Bio1_001399; Bio2_000228; Bio2_000708; BUMETANIDE [USP MONOGRAPH]; HMS1361L10; HMS1568H14; HMS1791L10; HMS1921B20; HMS1989L10; HMS2089P13; HMS2092N03; HMS2095H14; HMS2230P15; HMS3259O08; HMS3260B05; HMS3374E02; HMS3402L10; HMS3654B13; HMS3712H14; HMS3873C13; HMS5079F07; Pharmakon1600-01502004; MSK10495; Tox21_110088; Tox21_500162; CCG-40125; EBC-04409; HY-17468R; NSC758145; s1287; AKOS015896600; Tox21_110088_1; AC-8115; CS-1821; DB00887; FB19354; KS-5211; LP00162; NC00550; NSC 758145; NSC-758145; SDCCGSBI-0050150.P004; IDI1_000034; IDI1_033978; SMP1_000049; NCGC00015149-01; NCGC00015149-03; NCGC00015149-04; NCGC00015149-05; NCGC00015149-06; NCGC00015149-07; NCGC00015149-08; NCGC00015149-09; NCGC00015149-10; NCGC00015149-11; NCGC00015149-12; NCGC00015149-13; NCGC00015149-15; NCGC00015149-16; NCGC00015149-23; NCGC00015149-26; NCGC00022072-03; NCGC00022072-04; NCGC00022072-05; NCGC00022072-06; NCGC00022072-07; NCGC00022072-08; NCGC00260847-01; HY-17468; SBI-0050150.P003; AB00052253; B8248; EU-0100162; NS00009049; ST51014910; SW196834-3; D00247; EN300-122330; 3-butylamino-4-phenoxy-5-sulphamyl-benzoic acid; AB00052253-15; AB00052253-16; AB00052253_17; AB00052253_18; 3-n-butylamino-4-phenoxy-5-sulfamyl-benzoic acid; 3-n-butylamino-4-phenoxy-5-sulphamyl-benzoic acid; Q275926; SR-01000003062-2; SR-01000003062-4; SR-01000003062-7; BRD-K38197229-001-06-7; BRD-K38197229-001-17-4; BRD-K38197229-001-28-1; BRD-K38197229-001-29-9; Z1541758727; Bumetanide, British Pharmacopoeia (BP) Reference Standard; Bumetanide, European Pharmacopoeia (EP) Reference Standard; Bumetanide, United States Pharmacopeia (USP) Reference StandardTên gọi khác
Sản phẩm chứa Bumetanide
FORDIURAN 1 mg COMPRIMIDOSBURINEX 5 mg, compriméBURINEX 2 mg/4 ml IV, solution injectable en ampouleBURINEX 1 mg, compriméBumetanide - Industriale ChimicaBumetanide - Leo PharmaBumetanide - Solara Active Pharma SciencesBumetanide - Quimica SinteticaBumetanide - Unichem Laboratories LimitedBumetanide - MSN LaboratoriesBumetanideBumetanide
Trang 1/2
